In our study, we didn’t focus on a single biomarker, but rather on the global burden of disease in patients with type 2 inflammation with different related pathologies, which often present multiple increased values simultaneously (eg. AERD, blood eosinophilia and increased IgE level are more common in asthmatic patient). The gene discussed is IGHE; the disease is Increased total eosinophil count.